317 related articles for article (PubMed ID: 33583415)
1. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
[TBL] [Abstract][Full Text] [Related]
2. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
4. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
5. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
Ling Y; Tang S; Cao Y; Fu C
Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans.
Yang EH; McConnell JP; Lennon RJ; Barsness GW; Pumper G; Hartman SJ; Rihal CS; Lerman LO; Lerman A
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):106-11. PubMed ID: 16239595
[TBL] [Abstract][Full Text] [Related]
8. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
Zhang H; Gao Y; Wu D; Zhang D
BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
[TBL] [Abstract][Full Text] [Related]
9. Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.
Zhang Q; Zhang QQ; He JJ; Dong SQ; Lu Y
Diabetes Res Clin Pract; 2024 Jun; 212():111681. PubMed ID: 38677367
[TBL] [Abstract][Full Text] [Related]
10. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
11. Chronic inhibition of lipoprotein-associated phospholipase A
Prasad M; Lennon R; Barsness GW; Prasad A; Gulati R; Lerman LO; Lerman A
Int J Cardiol; 2018 Feb; 253():7-13. PubMed ID: 29306475
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
Li J; Zhou Z; Niu X; Li H
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
17. Causal effect of Lipoprotein-associated phospholipase A2 activity on coronary artery disease and myocardial Infarction: A Two-Sample Mendelian Randomization study.
Sun L; Zhu Z; Shi M; Jia Y; Yang P; Wang Y; Liu F; Zhang Y
Clin Chim Acta; 2021 Dec; 523():491-496. PubMed ID: 34740601
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease.
Otunctemur A; Sahin S; Ozbek E; Cekmen M; İnal A; Tulubas F; Dursun M; Besiroglu H; Koklu I
Andrologia; 2015 Aug; 47(6):706-10. PubMed ID: 25091174
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A2 and arterial stiffness evaluation in patients with inflammatory bowel diseases.
Theocharidou E; Tellis CC; Mavroudi M; Soufleris K; Gossios TD; Giouleme O; Athyros VG; Tselepis AD; Karagiannis A
J Crohns Colitis; 2014 Sep; 8(9):936-44. PubMed ID: 24529818
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
